173 related articles for article (PubMed ID: 18625691)
1. Human chorionic gonadotropin measurements in parathyroid carcinoma.
Rubin MR; Bilezikian JP; Birken S; Silverberg SJ
Eur J Endocrinol; 2008 Oct; 159(4):469-74. PubMed ID: 18625691
[TBL] [Abstract][Full Text] [Related]
2. Significance of HCG to distinguish parathyroid carcinoma from benign disease and in adding prognostic information: a hospital based study from Nepal.
Gupta SP; Mittal A; Sathian B
Asian Pac J Cancer Prev; 2013; 14(1):325-7. PubMed ID: 23534747
[TBL] [Abstract][Full Text] [Related]
3. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycosylated human chorionic gonadotropin in serum of testicular cancer patients.
Lempiäinen A; Hotakainen K; Blomqvist C; Alfthan H; Stenman UH
Clin Chem; 2012 Jul; 58(7):1123-9. PubMed ID: 22529110
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotropin subunit measurement in primary hyperparathyroidism.
Stock JL; Weintraub BD; Rosen SW; Aurbach GD; Spiegel AM; Marx SJ
J Clin Endocrinol Metab; 1982 Jan; 54(1):57-63. PubMed ID: 6274898
[TBL] [Abstract][Full Text] [Related]
6. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer.
Iles RK; Persad R; Trivedi M; Sharma KB; Dickinson A; Smith P; Chard T
Br J Urol; 1996 Jan; 77(1):61-9. PubMed ID: 8653319
[TBL] [Abstract][Full Text] [Related]
7. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
[TBL] [Abstract][Full Text] [Related]
8. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
9. Measurement of human chorionic gonadotropin-related immunoreactivity in serum, ascites and tumour cysts of patients with gynaecologic malignancies.
Grossmann M; Hoermann R; Gocze PM; Ott M; Berger P; Mann K
Eur J Clin Invest; 1995 Nov; 25(11):867-73. PubMed ID: 8582453
[TBL] [Abstract][Full Text] [Related]
10. Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases.
Cole LA
Int J Gynecol Cancer; 2014 Nov; 24(9):1709-14. PubMed ID: 25275660
[TBL] [Abstract][Full Text] [Related]
11. An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma.
Rubin MR; Silverberg SJ; D'Amour P; Brossard JH; Rousseau L; Sliney J; Cantor T; Bilezikian JP
Clin Chem; 2007 Aug; 53(8):1470-6. PubMed ID: 17599957
[TBL] [Abstract][Full Text] [Related]
12. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
Cole LA; Muller CY
Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
[TBL] [Abstract][Full Text] [Related]
14. Reduction in parathyroid adenomas by cinacalcet therapy in patients with primary hyperparathyroidism.
Minezaki M; Takashi Y; Ochi K; Mitsuoka R; Yamao Y; Kudo T; Kawanami D; Kobayashi K; Abe I
J Bone Miner Metab; 2021 Jul; 39(4):583-588. PubMed ID: 33409573
[TBL] [Abstract][Full Text] [Related]
15. hCG - related molecules and their measurement.
Szczerba A; Białas P; Pięta PP; Jankowska A
Ginekol Pol; 2016; 87(1):65-70. PubMed ID: 27306471
[TBL] [Abstract][Full Text] [Related]
16. [Choriogonadotropin measurements--critical assessment of new diagnostic possibilities].
Skałba P; Gajewska K; Bednarska-Czerwińska A
Ginekol Pol; 2004 Mar; 75(3):221-7. PubMed ID: 15181881
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
[TBL] [Abstract][Full Text] [Related]
18. [Urinary hCG beta-core fragment as a tumor marker for bladder cancer].
Yamanaka N; Kawabata G; Morisue K; Hazama M; Nishimura R
Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):700-6. PubMed ID: 8492514
[TBL] [Abstract][Full Text] [Related]
19. What we know about low-level hCG: definition, classification and management.
Kohorn EI
J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
[TBL] [Abstract][Full Text] [Related]
20. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
